New Enterprise Associates related stories
All articles and analysis
Mothers' app Peanut pulls in seed fundingLondon-based Peanut, an app for mothers, has secured an undisclosed amount of seed funding. Sweet Capital Investment and the Female Founders Fund led the round with participation from other investors that included Greycroft, Sound Ventures, New Enterprise Associates, Felix and Partech.
- VC-backed Arsanis goes public
Waltham, Massachusetts-based Arsanis Inc, a developer of targeted monoclonal antibodies for treating serious infectious diseases, has raised $40 million for its IPO after pricing its IPO of four million shares at $10 per share. The stock began trading November 16, 2017 on the NASDAQ under the ticker symbol "ASNS." Citigroup, Cowen and Company and Piper Jaffray & Co are the lead underwriters. And, in a separate transaction, New Enterprise Associates has agreed to provide $20 million to Arsanis in a private placement. Arsanis' pre-IPO backers include the Bill & Melinda Gates Foundation, GV, Alexandria Venture Investments, OrbiMed, Polaris Venture Partners, SV Health Investors, NeoMed, EMBL Ventures and the Anna Maria and Stephen Kellen Foundation.
NEA promotes Jacobson to partner, adds Patel as venture partnerNew Enterprise Associates announced the promotion of Aaron Jacobson to partner. And the firm added Dr. Kavita Patel as a venture partner on its healthcare team. Jacobson is an early-stage tech investor based in the San Francisco Bay Area. He joined the firm in 2011.
- Inozyme Pharma nabs $49 mln Series A
Inozyme Pharma Inc, a developer of treatments for rare diseases of calcification, affecting soft tissues and bone, has raised $49 million in Series A financing. Longitude Capital led the round with participation from other investors that included New Enterprise Associates, Novo Ventures and Sanofi Ventures.
- WireWheel.io reels in $3.1 mln seed
Arlington, Virginia-based WireWheel.io, a developer of a cloud-based data privacy and protection platform, has closed $3.1 million in seed financing. PSP Growth and New Enterprise Associates led the round with participation from other investors that included Steve Case.
- ThreatQuotient nabs $30 mln Series C
ThreatQuotient, a provider of a threat intelligence platform, has raised $30 million in Series C funding. Adams Street Partners led the round with participation from Cisco Investments, NTT DOCOMO Ventures Inc, New Enterprise Associates and Silicon Valley Bank. In conjunction with the funding, Fred Wang, a partner at Adams Street Partners, will join ThreatQuotient's board of directors.
- Elastic buys VC-backed Swiftype
Elastic has acquired San Francisco-based Swiftype, a provider of search software. No financial terms were disclosed. Swiftype is backed by Y Combinator and New Enterprise Associates.
- Oyster Point Pharmaceuticals rallies $22 mln Series A
San Francisco-based Oyster Point Pharmaceuticals Inc., a developer of treatments for dry eye and other diseases of the ocular surface, has closed $22 million in Series A financing. New Enterprise Associates and Versant Ventures led the round.
